A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors

Clinical trial NCT05564858 · UNKNOWN

Trial details

NCT number: NCT05564858
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-01-16
Primary completion: 2025-09-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.